PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Nov-2021 Recombinant Vaccines Market to Gain Enormous Traction: with growth of 6.1% CAGR by 2028 | Study By Future Market Insights MARKITWIRED
08-Nov-2021 Swiss Life Sciences Group Opens Funding Platform for the CBD Industry Newswire
08-Nov-2021 CD Formulation Offers Multiple Methods for Microbial Limit Test CD Formulation
08-Nov-2021 CD Formulation Optimizes Custom Excipient Development Options CD Formulation
08-Nov-2021 Alfa Chemistry Materials Announces to Offer Molecular Sieve for Scientific Research Alfa Chemistry Materials
05-Nov-2021 Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services Aragen
05-Nov-2021 CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025 CPhI Worldwide
04-Nov-2021 Global Softgel Capsules Market Report 2021: Market was Valued at $3.43 Billion in 2020 and is Projected to Reach $5.25 Billion by 2028 - ResearchAndMarkets.com Businesswire
04-Nov-2021 MD&M East Announces 2021 Keynote and Speaker Lineup Set to Deliver Technical and Forward-looking Insights Impacting Medical Device Manufacturers Businesswire
04-Nov-2021 Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update Businesswire
04-Nov-2021 Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021 Businesswire
04-Nov-2021 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
04-Nov-2021 PlateletBio Completes $75.5M Series B Financing Businesswire
04-Nov-2021 Ironwood Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with COUR Pharmaceuticals to Develop and Commercialize CNP-104 for the Treatment of Primary Biliary Cholangitis (PBC) in the U.S. Businesswire
04-Nov-2021 908 Devices Reports Third Quarter 2021 Financial Results Businesswire
04-Nov-2021 Moderna Reports Third Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Businesswire
04-Nov-2021 Cybin Granted DEA Schedule I Manufacturing License Businesswire
04-Nov-2021 Bicycle Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update Businesswire
04-Nov-2021 Molecular Diagnostics for Infectious Disease (by Syndrome, Plex, Place and Country) 2021 - 2025: New Genotypes Creating New Markets - ResearchAndMarkets.com Businesswire
04-Nov-2021 Bicycle Therapeutics Announces First Patient Dosed in Phase I/II Trial of Bicycle® Tumor-targeted Immune Cell Agonistâ„¢ BT7480 in Patients with Advanced Solid Tumors Associated with Nectin-4 Expression Businesswire